CoChat

Molecular Characterization of the Pediatric Preclinical Testing Panel

Open access
Neale, Geoffrey, Su, Xiaoping, Morton, Christopher L., Phelps, Doris, Gorlick, Richard, Lock, Richard B., Reynolds, C. Patrick, Maris, John M., Friedman, Henry S., Dome, Jeffrey, Khoury, Joseph, Triche, Timothy J., Seeger, Robert C., Gilbertson, Richard, Khan, Javed, Smith, Malcolm A., Houghton, Peter J. · 2008 · Clinical Cancer Research
Cited by 118

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Purpose: Identifying novel therapeutic agents for the treatment of childhood cancers requires preclinical models that recapitulate the molecular characteristics of their respective clinical histotypes. Experimental Design and Results: Here, we have applied Affymetrix HG-U133Plus2 profiling to an expanded panel of models in the Pediatric Preclinical Testing Program. Profiling led to exclusion of two tumor lines that were of mouse origin and five osteosarcoma lines that did not cluster with human or xenograft osteosarcoma samples. We compared expression profiles of the remaining 87 models with profiles from 112 clinical samples representing the same histologies and show that model tumors cluster with the appropriate clinical histotype, once “immunosurveillance” genes (contributed by infiltrating immune cells in clinical samples) are eliminated from the analysis. Analysis of copy number alterations using the Affymetrix 100K single nucleotide polymorphism GeneChip showed that the models have similar copy number alterations to their clinical counterparts. Several consistent copy number changes not reported previously were found (e.g., gain at 22q11.21 that was observed in 5 of 7 glioblastoma samples, loss at 16q22.3 that was observed in 5 of 9 Ewing's sarcoma and 4 of 12 rhabdomyosarcoma models, and amplification of 21q22.3 that was observed in 5 of 7 osteosarcoma models). We then asked whether changes in copy number were reflected by coordinate changes in gene expression. We identified 493 copy number–altered genes that are nonrandom and appear to identify histotype-specific programs of genetic alterations. Conclusions: These data indicate that the preclinical models accurately recapitulate expression profiles and genetic alterations common to childhood cancer, supporting their value in drug development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-07-5090

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 118

Metadata

Authors
Neale, G., Su, X., Morton, C. L., Phelps, D., Gorlick, R., Lock, R. B., Reynolds, C. P., Maris, J. M., Friedman, H. S., Dome, J., Khoury, J., Triche, T. J., Seeger, R. C., Gilbertson, R., Khan, J., Smith, M. A., & Houghton, P. J.
Venue
Clinical Cancer Research
Published
2008-07-15
Volume
14
Issue
14
Pages
4572-4583
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2122608679
Cited by
118
References
4
FWCI
4.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Characterization of the Pediatric Preclinical Testing Panel. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-07-5090
The paper
Neale, G., Su, X., Morton, C. L., Phelps, D., Gorlick, R., Lock, R. B., Reynolds, C. P., Maris, J. M., Friedman, H. S., Dome, J., Khoury, J., Triche, T. J., Seeger, R. C., Gilbertson, R., Khan, J., Smith, M. A., & Houghton, P. J. (2008). Molecular Characterization of the Pediatric Preclinical Testing Panel. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-07-5090

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.